Top, Oguz http://orcid.org/0000-0003-2820-6505
Milferstaedt, Stella W. L. http://orcid.org/0000-0003-3357-4177
van Gessel, Nico http://orcid.org/0000-0002-0606-246X
Hoernstein, Sebastian N. W. http://orcid.org/0000-0002-2095-689X
Özdemir, Bugra http://orcid.org/0000-0001-9823-0581
Decker, Eva L. http://orcid.org/0000-0002-9151-1361
Reski, Ralf http://orcid.org/0000-0002-5496-6711
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC-294, EXC-2193/1)
Bundesministerium für Bildung und Forschung (0313852C)
Article History
Received: 2 October 2020
Accepted: 26 July 2021
First Online: 12 August 2021
Competing interests
: The authors declare the following competing interests: All authors are inventors of patents and patent applications related to the production of recombinant proteins. R.R. is a founder of Greenovation Biotech (now eleva GmbH). He currently serves as advisory board member of this company. Eleva develops and markets moss-based biopharmaceuticals.